PCM
PMC

Peregrine Capital Management’s PharMerica Corporation PMC Stock Holding History

Peregrine Capital Management’s Portfolio PMC Stock Details PMC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-430,934
Closed -$11.3M – 259
2017
Q2 		$11.3M Buy
430,934
+8,615
+2% +$212K 0.28% 149
2017
Q1 		$10.2M Sell
422,319
-6,744
-2% -$166K 0.26% 153
2016
Q4 		$10.8M Sell
429,063
-35,537
-8% -$897K 0.28% 157
2016
Q3 		$13M Buy
+464,600
New +$11.9M 0.34% 125

Other funds holding PMC

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WIC
Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Peregrine Capital Management's PMC Position: Q3 2017 in Review

Peregrine Capital Management sold out of PharMerica Corporation (PMC) in Q3 2017, closing a stake of 430,934 shares — an estimated $11.3M sold.

Peregrine Capital Management first reported a position in PMC in Q3 2016 and held it in 4 quarters. The position peaked at $13M in Q3 2016. 150 funds tracked by Wall St. Rank hold PMC as of Q3 2017.

  • Peregrine Capital Management reported no remaining PharMerica Corporation position as of Q3 2017 after selling out during the quarter.
  • Peregrine Capital Management sold 430,934 PharMerica Corporation shares in Q3 2017, an estimated $11.3M.
  • Peregrine Capital Management first reported a position in PharMerica Corporation in Q3 2016 and held it in 4 quarters.
  • Peregrine Capital Management's PharMerica Corporation position peaked at $13M in Q3 2016.
  • 150 funds tracked by Wall St. Rank held PharMerica Corporation as of Q3 2017.

Based on Peregrine Capital Management's 13F filing for Q3 2017, filed 25 Oct 2017.